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Background: The zoonosis brucellosis causes economically significant reproductive problems in livestock and potentially
debilitating disease of humans. Although the causative agent, organisms from the genus Brucella, can be differentiated
into a number of species based on phenotypic characteristics, there are also significant differences in genotype that are
concordant with individual species. This paper describes the development of a five target multiplex assay to identify five
terrestrial Brucella species using real-time polymerase chain reaction (PCR) and subsequent high resolution melt
curve analysis. This technology offers a robust and cost effective alternative to previously described hydrolysis-probe
Single Nucleotide Polymorphism (SNP)-based species defining assays.
Results: Through the use of Brucella whole genome sequencing five species defining SNPs were identified. Individual
HRM assays were developed to these target these changes and, following optimisation of primer concentrations, it was
possible to multiplex all five assays in a single tube. In a validation exercise using a panel of 135 Brucella strains of
terrestrial and marine origin, it was possible to distinguish the five target species from the other species within this panel.
Conclusion: The HRM multiplex offers a number of diagnostic advantages over previously described SNP-based typing
approaches. Further, and uniquely for HRM, the successful multiplexing of five assays in a single tube allowing
differentiation of five Brucella species in the diagnostic laboratory in a cost-effective and timely manner is described.
However there are possible limitations to using this platform on DNA extractions direct from clinical material.
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Brucellosis is a zoonosis of great socio-economic import-
ance that causes reproductive problems including abor-
tions and sterility in large livestock such as cattle, sheep,
pigs and goats [1]. In humans, brucellosis can manifest
itself in many disparate ailments such as general malaise,
fever and arthritis in chronic cases [2]. Transmission
from animal to human is facilitated through contact with,
or ingestion of, infected material such as abortion tissue
or unpasteurised milk from infected animals [2].
The causative agents of brucellosis are organisms from
the genus Brucella. There are eight recognised species* Correspondence: Krishna.Gopaul@apha.gsi.gov.uk
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unless otherwise stated.within the genus that have been associated with brucellosis
in various terrestrial mammals and at least a further two
species associated with marine mammals [3]. However the
genus is expanding and recent isolations from baboons,
foxes, and frogs suggest that are more groups awaiting
description [4-6].
Classically, Brucella species are defined through a com-
bination of perceived host specificity and phenotypic char-
acterisation. In this way, B. abortus is typically associated
with brucellosis in bovines, B. melitensis with brucellosis in
caprines and ovines, B. suis with brucellosis in swine and
B. canis with canine brucellosis [3]. In ovines, B. ovis mani-
fests as ovine epididymitis in rams [1]. However there have
been isolations of Brucella species outside their perceived
hosts, for example, B. melitensis infection of cattle being
reported [7,8].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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developed for the rapid identification of Brucella spp
based on genus conserved targets such as bcsp31 [9] and
IS711 [10,11]. As these assays use DNA and not viable
bacteria, molecular methods for Brucella diagnosis can
be more safely used in a wider range of laboratories.
Furthermore, there are also molecular tests available that
have been developed that can rapidly discriminate to spe-
cies level from a primary isolation [9,12-17].
Whilst a number of these tests have been described in
the literature, there are two main groups. One group of
assays uses specific insertions/deletions identified through
genome characterisation of a number of Brucella species.
These tests include techniques such as AMOS PCR and
Bruceladder [12-14] based on a conventional PCR plat-
form as well as assays such as those described by Redkar
et al., [15] and Probert et al., [9] using a real time PCR
platform. The second group makes use of single nucleo-
tide polymorphisms (SNPs) identified through Multi-
Locus Sequence Analysis (MLSA) using hundreds of
Brucella strains from all species [18] or through whole
genome sequencing. Currently, all recognised and pro-
posed Brucella species have been identified with unique
MLSA sequence types [4-6,18] and assays have mostly
been developed using real-time PCR platforms and probe
based technologies [16,17]. Although these assays have
proven highly effective their implementation is hindered
by the expense associated with dual labelled hydrolysis
probe multiplexes [16,17] that make this type of testing
potentially difficult to apply in resource limited regions.
One alternative to using hydrolysis probe chemistry is
to use melt curves to determine the presence or absence
of a target SNP within an otherwise conserved region of
sequence [19,20]. In this scheme, during amplification,
an intercalating dye (typically SYBR green) binds to double
stranded DNA that forms, generating a fluorescence read-
ing. In the melt cycle, with the increase of temperature,
the double stranded product begins to separate and fluor-
escence drops. The melt peak (which is related to the
DNA composition of the product) occurs at a point where
50% of the product population is double stranded and
50% single stranded. Changes in the sequence alter the
melt temperature of the target. The major advantage of
this methodology over probe-based genotyping is that the
chemistry utilised is much cheaper, although this approach
has previously suffered from its inability to detect very
subtle but significant changes in melt temperatures [21]
Nevertheless, recent advances in both dye chemistry and
hardware, leading to the development of High Reso-
lution Melt (HRM) curve analysis, facilitates detection
of much smaller differences in temperature than previ-
ously achieved [22]. Indeed, HRM as a tool for genotyp-
ing has been shown to be of great utility [23] not only for
bacteria [24,25] but also for viruses [26] and eukaryoteparasites [27]. Furthermore, with pathogen detection and
genotyping, there are many examples in the literature of
the application of HRM for human genetics to characterise
genetic variation linked with various cancers [28,29] and
other ailments [30,31].
One previous study has described the use of HRM for
Brucella species identification [32]. However, as in the case
of the majority of other publications using HRM for geno-
typing, this previous study described using one or a
number of singular reactions for differentiation. This
type of approach in turn reduces the throughput of the
system making it less attractive for implementation. There-
fore the intention of this study was not only to develop
HRM assays as an alternative means of SNP-based
Brucella species determination but to also combine HRM
assays in one tube to improve throughput. To this end this
paper describes the creation of a quintuplex test that can
rapidly, cheaply and unambiguously define strain identity
for five terrestrial Brucella species of agro-economic
importance; B. abortus, B. canis, B. melitensis, B. ovis and
B. suis. Of these five species B. melitensis, B. abortus and
B. suis are the species associated with most economically
significant animal and human disease [1]. Concerning the
remaining two species, B. canis infects dogs and is occa-
sional cause of human infection whilst B. ovis is a minor
and far less-widely distributed animal pathogen.
Results
Identification of target SNPs
From multi-locus sequence analysis work described pre-
viously a number of SNPs that define particular Brucella
species have been identified [18]. This extensive work
examining a spatially and temporally diverse panel of >700
Brucella strains of all Brucella species provided the basis
for the subsequent multiple outcome species defining as-
says based on Minor Groove Binding (MGB) TaqMan®
probe chemistry [17]. It was therefore initially thought that
the same targets could be as the basis of the HRM assays.
However using the selection criteria described in the
methods section, it was found that none of the previ-
ously used targets were suitable markers for use in HRM
assays.
It was therefore decided to make use of the expanding
Brucella whole genome sequence (WGS) project database,
hosted by the Broad Institute, Massachusetts, USA. Al-
though this database is not currently as diverse and large
as the in-house MLSA, it does none the less provide
enough variation (in terms of Brucella species) to identify
potential markers. Through alignments of 35 Brucella spp
genome sequences available from the WGS project in
March 2010 (Table 1), potential canonical SNPs for the
determination of the five targeted Brucella species were
identified based on location in B. melitensis 16 M. Using
these data, regions flanking these SNPs were identified
Table 1 A breakdown of the 35 Brucella genomes used
for SNP discovery of species specific targets
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if they met the required criteria. Primers for those regions
deemed useful were then designed and tested on a small
panel of isolates comprising the type strains for B. abortus,
B. melitensis, B. ovis and B. canis (Table 2).
Titration work
To determine the sensitivity of discrimination of HRM
assays, titrations of the genomic DNA from the five target
Brucella species were prepared and tested. Through titra-
tions it was determined that the limit for reproducible dis-
crimination of the five individual HRM assays was 100 fg
(data not shown). It was noted that whilst using the nega-
tive first derivative of the data, there was no difference in
the positioning of melt peaks with changing DNA concen-
tration (Figure 1), there were changes in the kinetics of
the melt curve with DNA concentration (Figure 2). As
interpretation of the quintuplex was performed visually
(Figures 3 and 4), comparing the curve dynamic of the
sample with that of a known control on the same run,
low concentrations of non-target Brucella could be misin-
terpreted as high concentrations of the target species. In a
review of HRM, Reed et al. [33] mentioned that interpret-
ation of HRM data was better achieved through the com-
parison of melt curves rather than from the first derivative
melt peak which was subject to “data smoothing”. It was
for this reason that the decision was made to standardise
the amount of DNA tested to 1 ng/μl in subsequent work.
Development and validation of the quintuplex
Results of individual reactions for the five species-defining
assays demonstrated that the technique was promising,
although the issue of change in melt dynamic with the
variation in the amount of template added was of concern.
However, it was the intention from the conception of this
work to develop a species-defining quintuplex. This in
turn meant that there had to be 10 distinct meltingtemperatures to account for each species specific and
non-species specific melt. To do this, the melting tem-
peratures of the products of each assay were manipu-
lated to defined melt temperatures by adjusting product
size to ensure no overlap between each individual melt
peak that would render sample identification impossible.
The concentrations of primers added to the primer mix
were meticulously optimised to ensure high quality and
equally sized melt curves were generated for each species-
defining assay in the quintuplex. It was observed that each
of the species tested produced a distinct curve profile and
that those profiles of isolates not belonging to one of the
included five Brucella species, such as B. microti, are also
distinct (Figures 3 and 5).
In the validation of the quintuplex assay, highly purified
DNA from 135 isolates that had previously been identified
using both classical biotyping and the TaqMan probe
based real-time PCR approach (Table 3 for panel break-
down and Additional file 1 for complete strain identity)
were tested with the HRM multiplex assays. These isolates
were chosen to reflect the genetic diversity of the Brucella
species in question based on previous MLSA studies [18].
The results of the HRM work were that all 135 samples
tested gave species identification congruent with pheno-
typic and real-time PCR testing [17] (data not shown).
Specificity testing of Brucella spp assays
To determine the specificity of published Brucella genus
molecular diagnostics in an expanding Brucellaceae family,
two real time PCR assays based on the IS711 target [10,11]
and one based on the bcsp31 target [9] were used to test a
panel of 23 non- Brucella Brucellaceae (Table 4). It was
found that there were no false positive results generated
with any of the three assays generated (data not shown),
proving that these assays were specific to Brucella genus
organisms within the Brucellaceae family.
Discussion
Assay performance
From the testing of 135 Brucella isolates, it was observed
that the HRM targets and assays correctly identified all
isolates to the corresponding species, or in the cases of
B. ceti, B. inopinata, B. microti, B. neotomae, and B.
pinnipedialis as not being members of one of the spe-
cies included in the assay. These findings were encour-
aging as although SNPs derived through Brucella MLSA
work [18] had been rigorously tested with the sequencing
of hundreds of Brucella strains, the SNPs identified by
whole genome sequencing had been selected after compari-
son with a much smaller group of 35 sequenced Brucella
genomes. Although the test panel chosen for this work is
relatively small, the selection and testing of a wide number
of Brucella MLSA sequence types shows the robustness of
the SNPs chosen.
Table 2 Targets, primer sequences and final concentrations for each of the species-specific quintuplex HRM assays
Brucella species Forward primer sequence Reverse primer sequence Final concentration of primer
pair in quintuplex reaction (μM)
Product size (bp) Gene target (based on B. abortus 9-941)
B. abortus 5′-GCCCCTCCTTCTTGTAATCA-3′ 5′-ACCATGAAGAAAGCGCGTAT-3′ 1.25 μM 75 BruAb1_0395Hypothetical protein
B. melitensis 5′-ACAAGCTGACGAAGGACCAT-3′ 5′-CCCGTATAGGAGTGGATCGT- 3′ 0.5 μM 135 BruAb1_1713 glyceraldehyde-3-phosphate
dehydrogenase
B. ovis 5′-CCGGTCAAGTTCAATCACG-3′ 5′-GCTGGAAATGCTCTATTACTC-3′ 1 μM 66 BruAb1_1179 Hypothetical protein
B. suis 5′-CTGGCGGAAAAGGATTTGAT-3′ 5′-AATCACGACAAACCACAGCA-3′ 1.125 μM 89 BruAb1_1338 Sugar ABC transporter,
permeaseprotein




















Figure 1 Melt peaks of one HRM assay with titrations of target and non target DNA. The results of a titration range of 1 ng-100 fg genomic DNA
from B. melitensis 16 M (red) and B. abortus 544 (blue) using the B. melitensis HRM assay and the negative first derivative melt peak data. As shown, whilst
the peak size does vary with the concentration of DNA, there is clear differentiation between the two species.
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genotyping, with little downstream processing and a closed
tube excluding the hazards of product manipulation and
possible subsequent cross-contamination. In terms of ana-
lysis, data acquisition is rapid with a melt only taking a few
minutes post amplification. Data analysis is straightforward
with species assignment based on a visual comparison of
curve kinetics with reference strains on the same run
(Figure 3). Although there is an upfront hardware cost,
once purchased reagent prices are lower than those as-
sociated with Taqman-probe based SNP typing. In addition,
the testing for five Brucella species in one tube gives
equivalent resolution but at five times the throughput of in-
dividual assays such as those based on the use of hydrolysis
probes [17,18]. This is yet another cost reduction measure
presented by this HRM assay that makes the use of SNPs
for the identification of Brucella sequences more attractive.
In this study, the focus has been on the development
of a quintuplex focusing on five species that commonly
infect animals of agro-economic importance. However,
this work should also been seen as a proof of concept,
highlighting the possibility of multiplexing several SNP-
based species defining assays for better throughput andreduced costs. Although other studies have also demon-
strated the possibility of multiplexing HRM assays in
triplex and quadruplex format [34,35], this present work is
an example where five individual bacterial targets have
been characterised simultaneously in a single tube.
Comparison with other Brucella HRM assays
As mentioned earlier, the Brucella quintuplex HRM is
not the first example of the application of HRM for the
identification of Brucella species. Work published by
Winchell et al., [32] described the application of a number
of assays to comprehensively cover all known Brucella
species with the exception of B. inopinata. Further, the
incorporation of an assay for the direct identification of
members of the Brucella genus allows for direct identi-
fication from isolation, something that is not available
using the Brucella quintuplex. However, in defence of
the quintuplex, it should be stated that there are already a
number of Brucella real time PCR diagnostic assays avail-
able that have been validated on large panels of non-
Brucella organisms [9-11]. Any of these assays could be
used as a rapid screen to identify Brucella spp organisms.
Indeed, work undertaken within this department using a
Figure 2 Melt curves of one HRM assay with titrations of target and non target DNA. The results of a titration range of 1 ng-100 fg genomic
DNA from B. melitensis 16 M (red) and B. abortus 544 (blue) using the B. melitensis HRM assay and the HRM melt curves directly. Curves move from
right to left with decreasing DNA concentration. As shown, the curves generated by very low concentrations of B. abortus DNA are very close to the
curves generated by high concentrations of B. melitensis DNA and could be misidentified through this association.
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published assays based on IS711 [10,11] and bcsp31 [9] has
shown that these assays are Brucella spp specific even in
light of an expanding Brucellaceae genus (data not shown)
and thus, these assays could be used as an initial screen for
Brucella organisms prior to species differentiation.
In terms of targets, whilst both schemes use individual
SNPs for each species, the Winchell paper also includes
one target for two species; the gene glk for B. abortus
and B. ovis [32]. From MLSA data it can be seen that
whilst a majority of B. abortus strains tested do contain
the SNP identified as B. abortus specific by Winchell et al.,
[32] a significant subset of isolates of African origin, in-
cluding B. abortus biovar 3 type strain and field isolations
of B. abortus biovars 3 and 6 have the alternate state SNP
[18]. Further, to compound the issue, the SNP identified by
Winchell et al. [32], as specific to B. neotomae is also found
in the B. abortus biovar 3 type strain, leading to a possible
misidentification with this HRM assay, Winchell et al. [32]
do not state whether the B. abortus biovar 3 strain used
was the type strain or a field isolation but this one examplehighlights a potential limitation in the universal applicabil-
ity of this scheme.
Another major difference between the previously pub-
lished Brucella HRM assay and the proposed quintuplex
is the used of an insertion rather than a SNP to positively
identify B. suis isolates in the former. From the SNPs iden-
tified in the MLSA work published by Whatmore et al.,
[18] it was not possible to identify a B. suis specific SNP
that positively identified all five B. suis biovars but ex-
cluded B. canis. This reflects the phylogenetic placement of
B. canis as a terminal node within the B. suis clade. How-
ever, the authors also mention that they could not differen-
tiate B. suis biovar 4 from B. canis isolates, meaning that
there could be misidentifications between certain B. suis
and B. canis isolations. In comparison, the Brucella quintu-
plex uses SNPs derived from whole genome sequencing
for the identification of all B. suis biovars and it has
been shown to identify type strains from all five biovars
in addition to clinical isolations. This is an improvement
over previous hydrolysis probe based Brucella SNP assays
that could not identify B. suis biovar 5. Previous molecular
Figure 3 Determination of species identity based on melt curve kinetics. This figure gives an example of the diagnostic analysis of an unknown
sample (green curve) comparing melt curves with curves generated in the quintuplex assay by representative strains of known Brucella species
(grey curves). Species identification is based on “best match” with the curves in this case clearly indicating that the query strain is B. melitensis.
Note that curves generated by B. microti isolates, not a target species for this assay, are shown to illustrate that a novel trace is generated for
species out-with the target scope.
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lysis and MLSA had suggested that B. suis biovar 5 might
be considered a novel Brucella species [18,36] although re-
cent WGS analysis does confirm the placement of B. suis
biovar 5 as a very early branch in the B. suis/B. canis clade
[37,38]. Though B. canis shares this SNP, the quintuplex
makes use of a unique B. canis SNP to separate this
species, and despite this being an indirect testing algo-
rithm it at least excludes the possibility of samples being
misidentified.
Issues with the use of HRM
Although the reagent costs of running HRM assays are
significantly cheaper than that of the equivalent hy-
drolysis probe real-time PCR tests, there are some is-
sues that could potentially diminish the usefulness HRM
for typing. Although the design process for HRM primersis straightforward, target choice is hampered by the need
for minimum secondary structure. Evidence of this has
been seen early in this current study with the inability
to design HRM assays to targets previously used for hy-
drolysis probe based assays [17].
Further, this technique cannot identify the location of
target SNP and so if there is a substitution that causes
identical change in melt temperature elsewhere in the
fragment other than the region of interest, this will be
miscalled. Nevertheless, the known lack of genetic diver-
sity in classical Brucella species [3] suggests this is unlikely
to be an issue for Brucella spp HRM assay development.
In this study, it was observed that when titrations of
different Brucella species were compared the limit of
reproducible species identification for each of the five
individual HRM assays was 100 fg or approximately 30
bacterial cells. Winchell et al., [32] also found that this
Figure 4 Melt curve kinetics for quintuplex target species. Melt profiles illustrating the unique HRM curves generated by the quintuplex for
B. abortus (black), B. melitensis (green), B. ovis (light blue), B. suis (dark blue) and B. canis (purple). Each region of differentiation is highlighted.
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suggested that there may be a role for this type of test-
ing in the direct typing of Brucella species from clinical
material. However, whilst the sensitivity of the technique
in determining species from purified DNA is clear, there
are doubts as to the usefulness of HRM assays where the
input DNA is not quantified. In this study, from the tests
of titrations of target DNA as well as in other published
work on HRM [21,25,30], it was shown that melt curve
characteristics are affected by the initial concentration
of DNA template in the reaction. Another worrying ob-
servation reported in relation to the previously published
Brucella HRM assay was the greater amount of DNA re-
quired for reproducible identification using the B. melitensis
assay [32], intimating that at lower concentrations, incor-
rect typing results may be obtained. Whilst DNA quantifi-
cation is straightforward in the case of test application
following bacterial isolation, this would be problematic in
field samples where the large excess of host DNA makes
quantification of pathogen DNA impossible. In contrast,
prior DNA quantification is not an issue for SNP based typ-
ing using hydrolysis probes. If a sample is positive using
Brucella spp real time PCR assays, in theory it should be
possible to undertake SNP typing using hydrolysis probes.A further drawback is the fact that the melting tem-
perature of DNA in this technique is not only depend-
ant on the concentration of template pre-amplification
but also on ionic conditions [21]. In turn this means
not only does the sample need quantification pre-
amplification but that the extraction methods and how
the sample storage matrices. This may have implications
for the type of sample that can be tested using this tech-
nique, with crude extractions (e.g. heat inactivated cells)
possibly being problematic. However, this can be rectified
by running these extractions thorough a commercial DNA
extraction kit.
In spite of these issues, the demonstration of the
possibility to multiplex SNP-based HRM assays is a
major selling point for this technology. In contrast,
the rigidness of the two fluorophore hydrolysis probe
method only allows for two possible outcomes per re-
action; does this sample possess or lack the SNP that
is targeted in this reaction. However, whilst the HRM
method does improve throughput by the combination
of assays, it should be noted that this method de-
scribed in this paper requires the use of known Bru-
cella strains in every run to allow for comparison with
unknown samples.
Table 3 A breakdown of the 135 Brucella strains used in
the validation of the HRM quintuplex













Figure 5 Melt curve kinetics for quintuplex non target species. This figure illustrates how a Brucella isolate that is not a member of one of
the five major species would be excluded by this assay. The curves in grey are traces from the five species targeted by the quintuplex whilst the
traces in blue represent a non-target Brucella species (in this case B. microti). The blue traces are not congruent with any of the grey traces indicting that
the sample tested represents a species not included in this assay.
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multiplex reactions to allow for “one tube” species iden-
tification on a real-time PCR platform. In this study, five
targets were combined to allow for the identification of
five terrestrial Brucella species. This was done through
the variation of the product sizes and primer concentra-
tions for each of the assays used. There are SNPs that
can identify all recognised Brucella species (currently ten
in total) and vaccine strains [18,39, A. M. Whatmore and
M. S. Koylass unpublished data]. Nevertheless, although it
has been suggested that larger multiplex reactions may be
possible [35], given the way the data is currently analysed
in the quintuplex, the addition of further Brucella targets
for vaccines and other species to the described assay may
make the interpretation of data generated more difficult
and thus, full characterisation may require the running of
several HRM multiplex reactions.
Conclusion
In conclusion, the HRM technique is a highly accurate
method for typing Brucella to species level based on sin-
gle diagnostic SNPs. It is a simple and rapid closed tube
Table 4 A list of non- Brucella Brucellaceae used to
determine the specificity of three published Brucella spp
assays
Name Strain number
Ochrobactrum anthropi LMG 3331
Ochrobactrum ciceri DSM 22292
Ochrobactrum cytisi DSM 19778
Ochrobactrum daejeonense JCM 16234
Ochrobactrum gallinifaecis DSM 15295
Ochrobactrum grignonense LMG 18954
Ochrobactrum haematophilum CIP 109452
Ochrobactrum intermedium LMG 3301
Ochrobactrum lupini DSM 16930
Ochrobactrum oryzae DSM 17471
Ochrobactrum pecoris CCUG 60088
Ochrobactrum pituitosum DSM 22207
Ochrobactrum pseudogrignonense CIP 109451
Ochrobactrum pseudintermedium DSM 17490
Ochrobactrum rhizosphaerae DSM 19824
Ochrobactrum thiophenivorans DSM 7216
Ochrobactrum tritici LMG18957
Paenochrobactrum gallinarii CCUG 57736
Paenochrobactrum glaciei JCM 15115
Pseudochrobactrum asaccharolyticum CCUG 46016
Pseudochrobactrum kiredijianiae DSM 19762
Pseudochrobactrum lubricatis CCUG 56963
Pseudochrobactrum saccharolyticum CCUG 33852
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design is straight forward using freeware tools and the
chemistry utilised is much cheaper to run than the chemis-
try utilised by hydrolysis-probe mediated SNP identification,
allowing for wider use of Brucella SNPs for molecular-based
species identification. In this study, through optimisation of
primer concentrations, it was possible to multiplex five
Brucella species-identifying HRM assays in one tube
allowed for a much higher throughput than the equivalent
assays based on hydrolysis probe chemistry. Although lim-
itations in the number of targets that can be multiplexed
in one reaction have been identified, the HRM platform is
open and there is the potential to add further Brucella
SNP-based HRM assays to allow for more comprehensive
identification.
However, whilst the quintuplex provides a useful and
cheaper alternative to that of hydrolysis probes for real-
time SNP typing when applied to bacterial culture ma-
terial, these techniques may not be appropriate for direct
testing from clinical material as there are constraints
regarding condition quantification of DNA samples prior
to amplification.Methods
SNP discovery and assay development
Data from both the AHVLA Brucella MLSA scheme and
from an international whole genome sequencing project
hosted by the Broad Institute, Cambridge, USA (http://
www.broadinstitute.org/annotation/genome/brucella_group/
MultiHome.html) were used to identify SNPs (and associ-
ated flanking sequence of 100 bp) specific to the five most
significant Brucella species; B. abortus, B. melitensis, B. ovis,
B. suis and B. canis. The criteria for target choice were
the presence of only one known SNP per amplicon, and
amplicon size of between 70 bp and 250 bp. Overall
amplicon sizes for the different species targets were stag-
gered to allow for subsequent multiplexing of assays. Sec-
ondary structure in potential targets was determined using
the DINAMelt programme available freely online (http://
mfold.rna.albany.edu/?q=DINAMelt) and regions with a
change in Gibbs Free energy (ΔG) value > -1 were taken
forward and used as the basis for subsequent primer
design. Primers were then designed using the Primer 3
software (http://frodo.wi.mit.edu/primer3/). For each tar-
get selected, a number of primer combinations were gen-
erated by this software, synthesised and tested in simplex
reactions.
HRM reaction set up and analysis
Reactions were run in a volume of 25 μl using Qiagen
Type-it® HRM™ PCR mix (Qiagen, Crawley, West Sussex,
United Kingdom). Each reaction contained final concen-
trations of 1x HRM Type-it™ mix (Qiagen, Crawley, West
Sussex, United Kingdom) and 0.7 μM forward and reverse
primer (for each target). Each sample was tested in dupli-
cate. Reactions were run on a Qiagen Rotorgene-Q 5-plex
machine (Qiagen, Crawley, West Sussex, United Kingdom)
with temperature cycling parameters for the amplification
stage being a hold of 95°C for 5 minutes, followed by 40 cy-
cles of 95°C for 10 seconds, 60°C for 30 seconds, and 72°C
for 20 seconds. For the HRM stage, fluorescence record-
ings were made over the range of 65-95°C by increments
of 0.1°C. A normalised graph was generated using normal-
isation regions of 73-75°C and 86-88°C.
To determine the sensitivity of differentiation, titrations of
genomic DNA from four species (B. abortus, B. melitensis,
B. ovis and B. suis) were prepared from 1 ng/μl to 100 ag/μl
and tested with single HRM assays. For all subsequent work
DNA samples were quantified and standardised to 1 ng/μl
prior to testing.
Assays were first tested individually to determine suit-
ability for further work. After the species specificity of
each individual assay had been determined, multiplexing
was attempted. With multiplexing of assays, only primer
concentrations for the species-specific assays were varied
to allow for optimum differentiation of samples from dif-
ferent Brucella species. Once concentrations of each assay
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Brucella isolates was selected to validate the multiplex
(Table 2 for species composition; Additional file 1: Table S1
for further characterisation). The strains used in this study
form part of a collection of bacterial isolations held at
AHVLA. As only bacterial DNA from this collection
was used as testing material, this work did not require
approval through the AHVLA ethics committee. Strain
identity was assigned based on the visual similarity of
the melt curve generated by the unknown to melt curves
generated by reference strains of the five target species. As
there was no means of storing these reference curves
generated for analysis over different runs it was necessary
to include an example of each of the five target species in
every run undertaken.
Set up for Brucella spp real time PCR assays
The real time PCR assays used for this section of this
study were run as published [9-11] with the following
amendments. For DNA template, 2 μl of heat inactivated
bacterial culture suspension was used for each of the
Brucellaceae species tested (Table 4). This material was
previously indentified and confirmed as being fit for PCR
using 16SrRNA sequencing [40].
Additional file
Additional file 1: Table showing the test panel of 135 Brucella strains
used for the validation of HRM quintuplex assay including full strain
identity.
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